ADELAIDE, Australia, June 24, 2020 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the New Drug Application (NDA) for E4/DRSP to prevent pregnancy has been accepted for review by the US Food and Drug…Original Article
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US
